InsidersTradesSigma
Track the ORTHOCELL LIMITED stock price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €197.4m. The latest transaction was filed on 20 July 2026 (Purchase). The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Orthocell Limited is an Australian Securities Exchange listed company focused on developing tissue regeneration solutions. It specializes in innovative treatments for musculoskeletal injuries and conditions.